IRIS
CASO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.049
NA - Nord America 2.600
AS - Asia 2.290
SA - Sud America 312
AF - Africa 52
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.315
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.498
RU - Federazione Russa 1.597
SG - Singapore 1.234
IT - Italia 584
HK - Hong Kong 505
CN - Cina 368
BR - Brasile 284
DE - Germania 163
IE - Irlanda 148
NL - Olanda 139
FR - Francia 129
FI - Finlandia 97
CA - Canada 83
GB - Regno Unito 51
IN - India 47
SE - Svezia 42
VN - Vietnam 32
UA - Ucraina 27
CI - Costa d'Avorio 24
KR - Corea 22
BD - Bangladesh 20
ES - Italia 16
ZA - Sudafrica 13
TR - Turchia 11
AT - Austria 10
IQ - Iraq 10
MX - Messico 10
AU - Australia 9
EC - Ecuador 8
BE - Belgio 7
CZ - Repubblica Ceca 7
PL - Polonia 7
SA - Arabia Saudita 7
UZ - Uzbekistan 6
AR - Argentina 5
CH - Svizzera 5
CO - Colombia 5
MA - Marocco 5
TN - Tunisia 5
VE - Venezuela 5
GR - Grecia 4
ID - Indonesia 4
NP - Nepal 4
PK - Pakistan 4
HR - Croazia 3
JO - Giordania 3
JP - Giappone 3
LT - Lituania 3
PR - Porto Rico 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
EG - Egitto 2
EU - Europa 2
PA - Panama 2
PE - Perù 2
PT - Portogallo 2
AM - Armenia 1
BG - Bulgaria 1
CL - Cile 1
CR - Costa Rica 1
DZ - Algeria 1
GA - Gabon 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 8.315
Salva come PNG Salva come JPEG
Città #
Singapore 837
Hong Kong 503
Moscow 466
Santa Clara 277
Chandler 269
Ashburn 188
Millbury 180
Naples 161
Des Moines 116
Amsterdam 108
Princeton 102
Nanjing 88
Boston 85
Napoli 71
Lawrence 63
Hefei 54
Ottawa 52
Munich 50
Wilmington 42
Beijing 40
Milan 38
Nanchang 34
Cava de' Tirreni 27
Helsinki 25
Seattle 23
Seoul 22
Dublin 21
Rome 21
Falkenstein 20
São Paulo 18
Hangzhou 17
Turku 17
Los Angeles 16
Nuremberg 16
Washington 14
Hebei 13
Redwood City 13
Shenyang 13
The Dalles 13
Toronto 13
Woodbridge 13
Dong Ket 12
Jacksonville 12
Belo Horizonte 11
Düsseldorf 11
Fairfield 11
Hanoi 11
Jiaxing 11
Frankfurt am Main 10
Fuzhou 10
Tianjin 10
Brooklyn 9
Chennai 8
New York 8
Boardman 7
Campinas 7
Changsha 7
Kochi 7
Kunming 7
Porto Alegre 7
Springfield 7
Brussels 6
London 6
Mexico City 6
Shanghai 6
Ankara 5
Curitiba 5
Houston 5
Lanzhou 5
Norwalk 5
Salvador 5
San Francisco 5
Tashkent 5
Brasília 4
Brisbane 4
Brno 4
Campoli del Monte Taburno 4
Charlotte 4
Chicago 4
Contagem 4
Fremont 4
Guangzhou 4
Guayaquil 4
Lauterbourg 4
Mumbai 4
Nova Iguaçu 4
Paris 4
Phoenix 4
Piracicaba 4
Prineville 4
Pune 4
Ribeirão Preto 4
Rochdale 4
Stockholm 4
Sydney 4
Vienna 4
Warsaw 4
Amman 3
Aparecida de Goiânia 3
Atlanta 3
Totale 4.511
Salva come PNG Salva come JPEG
Nome #
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: A randomised, controlled, crossover study 108
Analysis of rheumatoid- vs psoriatic arthritis synovial fluid reveals differential macrophage (CCR2) and T helper subsets (STAT3/4 and FOXP3) activation 86
Comparison of effectiveness and safety ofinfliximab, etanercept, and adalimumab in psoriatic arthritis patients whoexperienced an inadequate response to previous disease-modifying antirheumaticdrugs. 85
Fragility Fractures in Patients with Psoriatic Arthritis 84
A reverse translational approach reveals the protective roles of Mangifera indica in inflammatory bowel disease 82
Association between small dense LDL and sub-clinical atherosclerosis in patients with psoriatic arthritis 79
Accelerated bone turnover identifies hemiplegic patients at higher risk of demineralization 78
Dactylitis in enteropathic spondyloarthritis 75
IL-17-induced inflammation modulates the mPGES-1/PPAR-gamma pathway in monocytes/macrophages 75
Rheumatic complaints in women taking aromatase inhibitors for treatment of hormone-dependent breast cancer. 71
Small molecule therapy for managing moderate to severe psoriatic arthritis 71
Mud-bath therapy and oral glucosamine sulfate in patients with knee osteoarthritis: a randomized, controlled, crossover study 70
The potential role of bone scintigraphy in the detection of deep muscular fascia involvement and calcinosis cutis in anti-synthetase syndrome 68
Alopecia areata in a patient with psoriatic arthritis and Crohn's disease receiving etanercept 67
Cardiovascular Risk Markers and Major Adverse Cardiovascular Events in Psoriatic Arthritis Patients 67
Magnetic resonance imaging of nail unit in psoriatic arthritis 67
Pharmacological treatment of spondyloarthritis: exploring the effectiveness of nonsteroidal anti-inflammatory drugs, traditional disease-modifying antirheumatic drugs and biological therapies 66
Psoriatic arthritis and psoriasis: differential diagnosis 66
Il methotrexate nella terapia dell'artrite periferica in corso di rettocolite ulcerosa 66
Clinical effects of mud-bath therapy and oral glucosamine sulfate after 6 months of discontinuation in patients with knee osteoarthritis: results from a randomised, controlled, crossover study 65
Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in dermatologic and rheumatologic patients already under treatment 65
The use of TNF-? blockers in psoriatic arthritis patients with latent tuberculosis infection. 64
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms 64
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 63
Association between Leeds Dactylitis Index and ultrasonographic features: a multicentre study on psoriatic hand dactylitis 62
Thalassemic Trait Prevalence in Patients Affected by Psoriatic Arthritis in Anti-TNF Treatment 61
Metabolic syndrome in psoriatic arthritis: the interplay with cutaneous involvement. Evidences from literature and a recent cross-sectional study 61
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 61
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 59
Simple clinical indicators for early psoriatic arthritis detection 58
May the analysis of 1918 influenza pandemic give hints to imagine the possible magnitude of Corona Virus Disease-2019 (COVID-19)? 57
JAK/STAT/PKC? molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis 57
Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study 57
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 57
Psoriatic arthritis is associated with increased arterial stiffness in the absence of known cardiovascular risk factors: a case control study 56
Refractory pemphigus foliaceus and Beh?et?s disease successfully treated with tocilizumab 56
Vascular perfusion kinetics by contrast-enhanced ultrasound are related to synovial microvascularity in the joints of psoriatic arthritis 56
The enthesopathy of celiac patients: Effects of gluten-free diet 56
Serum amyloid-A in Beh?et's disease. 55
Transcriptional network profile on synovial fluid T cells in psoriatic arthritis 55
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 55
Diagnosis and classification of relapsing polychondritis 55
Predominant ultrasonographic extracapsular changes in symptomatic psoriatic dactylitis: results from a multicenter cross-sectional study comparing symptomatic and asymptomatic hand dactylitis 55
Effectiveness of steroid injection for hand psoriatic dactylitis: results from a multicentre prospective observational study 55
Paradoxical onset of psoriatic arthritis during treatment with biologic agents for plaque psoriasis: a combined dermatology and rheumatology clinical study. 54
Biological treatments in Behçet's disease: beyond anti-TNF therapy 54
Anakinra treatment in drug-resistant Behcet’s disease: a case series 54
Interleukin-17A (IL-17A): A silent amplifier of COVID-19 54
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues. 53
Metabolic syndrome and its relationship with the achievement of minimal disease activity state in psoriatic arthritis patients: an observational study 53
Telerheumatology in COVID-19 era: a study from a psoriatic arthritis cohort 53
TNFα-inhibitors for ankylosing spondylitis and nonradiographic axial spondyloarthritis 53
COVID-19 clinical spectrum in psoriatic arthritis patients on biologics and tsDMARDs: results from a cohort at an Italian epicentre of the pandemic's third wave 53
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 52
The definition and measurement of axial psoriatic arthritis 52
Decrease of serum C-reactive protein levels in psoriatic arthritis patients treated with TNF alpha blockers 52
Treatment options: NSAIDs and DMARDs 52
Symptomatic psoriatic dactylitis is associated with ultrasound determined extra-synovial inflammatory features and shorter disease duration 52
IL-17A neutralizing antibody regulates monosodium urate crystal-induced gouty inflammation 52
The anti-drug antibodies detection: a valuable tool for clinical response loss in psoriatic patients? 52
Blau syndrome and latent tubercular infection: an unresolved partnership 51
PFAPA syndrome and Behçet's disease: a comparison of two medical entities based on the clinical interviews performed by three different specialists 51
Coeliac disease is a risk factor for the development of seronegative arthritis in patients with autoimmune thyroid disease 51
New developments in magnetic resonance imaging of the nail unit. 50
Efficacy of tocilizumab in a patient with refractory psoriatic arthritis 50
The enthesopathy of celiac patients: effects of gluten-free diet 50
Performances of five risk algorithms in predicting cardiovascular events in patients with Psoriatic Arthritis: An Italian bicentric study 50
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 50
Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset “sine psoriasis” 50
Erratum: Management of adult-onset Still's disease with interleukin-1 inhibitors: Evidence- And consensus-based statements by a panel of Italian experts (Arthritis Res Ther (2019) 21:275 DOI: 10.1186/s13075-019-2021-9) 50
Amplifying the concept of psoriatic arthritis: The role of autoimmunity in systemic psoriatic disease 49
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 48
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 47
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 47
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease 46
Quantitative imaging by pixel-based contrast-enhanced ultrasound reveals a linear relationship between synovial vascular perfusion and the recruitment of pathogenic IL-17A-F(+)IL-23(+) CD161(+) CD4(+) T helper cells in psoriatic arthritis joints 46
Improving telemedicine and in-person management of rheumatic and autoimmune diseases,during and after COVID-19 pandemic outbreak. Definite need for more Rheumatologists. Response to: 'Can telerheumatology improve rheumatic and musculoskeletal disease service delivery in sub-Saharan Africa?' by Akpabio et al 46
Comparison of efficacy and safety of infliximab (INF), etanercept (ETN) and adalimumab (ADA) in psoriatic arthritis patients who experienced an inadequate response to previous disease modifying antirheumatic drugs 45
Canakinumab efficacy in refractory adult-onset PFAPA syndrome 45
Psoriatic disease treatment nowadays: unmet needs among the "jungle of biologic drugs and small molecules". 45
Incidence of malignancies in a cohort of psoriatic arthritis patients taking traditional disease modifying antirheumatic drug and tumor necrosis factor inhibitor therapy: An observational study 44
Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: A retrospective observational multicenter study on 15 patients 44
Early psoriatic arthritis 43
Comparison of effectiveness and safety of infliximab, etanercept, and adalimumab in psoriatic arthritis patients who experienced an inadequate response to previous disease-modifying antirheumatic drugs. 42
Emerging drugs for psoriatic arthritis 42
Ultrasound Effectiveness of Steroid Injection for hand Psoriatic Dactylitis: Results from a Longitudinal Observational Study 42
Effectiveness and safety profile of tofacitinib and baricitinib in rheumatoid arthritis patients: results from a 24-month real-life prospective study in Southern-Italy 41
Impact of 24 months of anti-TNF therapy versus methotrexate on body weight in patients with rheumatoid arthritis: a prospective observational study 41
Scores versus clinical profiles in therapeutic decisions: a positive example from the Italian Medicines Agency (AIFA) decisions in the field of osteoporosis 41
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 41
Ultrasonographic Evidence of Predominance of Acute Extracapsular and Chronic Intrasynovial Patterns in 100 Cases of Psoriatic Hand Dactylitis 41
A machine-learning approach to cardiovascular risk prediction in psoriatic arthritis 41
JAK Inhibitors in Psoriatic Disease 40
Ex vivo signaling protein mapping in T lymphocytes in the psoriatic arthritis joints 40
Interaction between microbiome and host genetics in psoriatic arthritis 40
Performance and calibration of the algorithm ASSIGN in predicting cardiovascular disease in Italian patients with psoriatic arthritis 40
From autoinflammation to autoimmunity: old and recent findings 39
Acute and chronic pain in orthopaedic and rheumatologic diseases: mechanisms and characteristics 39
Autoinflammatory granulomatous diseases: from Blau syndrome and early-onset sarcoidosis to NOD2-mediated disease and Crohn's disease 39
Retention rates and identification of factors associated with anti-TNFα, anti-IL17, and anti-IL12/23R agents discontinuation in psoriatic arthritis patients: results from a real-world clinical setting 39
Totale 5.527
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.719
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.719
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021257 50 4 11 10 40 29 10 4 47 13 22 17
2021/2022775 8 6 1 0 2 33 3 34 143 32 125 388
2022/2023820 166 24 26 42 96 80 6 90 104 109 65 12
2023/2024741 32 106 120 48 33 86 16 52 13 10 142 83
2024/20255.038 406 368 25 77 88 306 503 311 445 508 1.545 456
2025/2026192 192 0 0 0 0 0 0 0 0 0 0 0
Totale 8.631